A firm has spent $2 million on R&D associated with a new product. These costs have been expensed for tax purposes, and they cannot be recovered if the new project is rejected.
Which Of The Following Is Not A Cash Flow And Thus Should Not Be Reflected In The Analysis Of A Capital Budgeting Project?